Langar Global HealthTech ETF
$10.45+0.10 (+0.97%)
- Expense ratio
- 0.85%
- Fund size
- $2M
- 1Y return
- +1.4%
- Yield · Last 12 months
- —
- Holdings
- 30
- Volume · 30D
- 0M sh
- NAV per share
- $10.21
- 52W range
The ETF.net LGHT Grade
Score 11 of 100 sits in the F band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E. A structural cap ceilings this fund at 40, so B and A are out of reach.
Cost
What you pay to own it — the expense ratio plus trading frictions, ranked within its category.FScore 4Category rankMission
How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.Not scoredRisk
How violently it can move — volatility, drawdown depth, and downside capture versus its category.FScore 16Category rankTradability
How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.FScore 4Category rankHoldings
What it actually owns — the quality, breadth, and concentration of the underlying portfolio.DScore 30Category rankDurability
Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.FScore 23Category rank
Our read on LGHT
FA concentrated bet on the machines and software behind modern medicine: actively managed, global in reach, and pointed at healthcare technology rather than the pharma-heavy sector index everyone else owns.
The Fund seeks long-term growth of capital. It is actively managed and invests at least 80% of assets in exchange-listed healthcare-technology equities and ADRs, principally in the United States and certain developed countries.
Why people hold it
- Narrow by design: at least 80% of assets sit in exchange-listed healthcare-technology stocks and ADRs, not the whole drugmakers-and-insurers sector.
- Casts wider than the typical health-care sector fund: US plus developed international names, reachable directly or through ADRs.
- Actively managed toward long-term growth of capital, so the manager can rotate holdings as the field shifts instead of waiting on an index reconstitution.
Worth knowing
- Charges 0.85% a year, a multiple of what the broad health-care index heavyweights in its peer group (VHT, XLV, FHLC) charge.
- Small and thinly traded, so bid-ask spreads and order size carry more weight here than in a mega-fund.
- A 2024 launch built for capital growth, not income: short operating history and no record of regular distributions.
LGHT Holdings
- Stocks
- 30
- 76%
- MRNA
Sectors
- Health Care100.0%
Geography
- United States85.37%
- Germany5.62%
- Netherlands4.78%
- Switzerland3.92%
- Ireland0.31%
LGHT Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | LGHT |
|---|---|
| Year to date | +3.3% |
| 1 month | +0.6% |
| 3 months | +28.0% |
| 1 year | +1.4% |
| 3 years | — |
| 5 years | — |
| 10 years | — |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | LGHT |
|---|---|---|
| 2026 YTD | +3.3% | |
| 2025 | −1.6% | |
| 2024 | −0.2% |
LGHT in the news
ETF.net Research hasn’t filed on LGHT yet — coverage lands here as it’s written.
LGHT Dividends
No distributions in the last 12 months.
LGHT Risk
- 18.0%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- −0.10
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −28.6%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 0.63
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
LGHT Cost
- The middle half of Health Care (Broad) funds
- Median 0.50%
23 of the 25 Health Care (Broad) funds charge less.